PRELUDE CAPITAL MANAGEMENT, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 74 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$323,000
+1694.4%
55,008
+1619.0%
0.02%
+1050.0%
Q3 2017$18,000
-61.7%
3,200
-64.4%
0.00%
-66.7%
Q4 2016$47,000
+2250.0%
9,000
+800.0%
0.01%
Q3 2016$2,000
-95.3%
1,000
-83.3%
0.00%
-100.0%
Q1 2015$43,0006,0000.01%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders